NPI: 1891721940 · BRONX, NY 10472 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/23/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/23/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,626 | $127K |
| 2019 | 17,875 | $1.18M |
| 2020 | 48,453 | $3.48M |
| 2021 | 57,110 | $3.88M |
| 2022 | 55,896 | $4.02M |
| 2023 | 36,489 | $3.88M |
| 2024 | 23,524 | $3.18M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 54,390 | 4,774 | $12.61M |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 25,810 | 2,213 | $5.95M |
| A4657 | Syringe, with or without needle, each | 64,460 | 7,053 | $1.14M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 40,128 | 4,179 | $47K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 3,030 | 1,626 | $3K |
| 90674 | 236 | 233 | $3K | |
| 90747 | 25 | 25 | $1K | |
| 90661 | 28 | 28 | $920.16 | |
| J1756 | Injection, iron sucrose, 1 mg | 20,340 | 4,998 | $503.28 |
| G0008 | Administration of influenza virus vaccine | 312 | 309 | $290.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 30,430 | 2,712 | $274.52 |
| 83970 | 512 | 410 | $124.67 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 324 | 263 | $84.81 |
| 82728 | 219 | 198 | $54.52 | |
| G0010 | Administration of hepatitis b vaccine | 13 | 13 | $46.60 |
| 85041 | 672 | 578 | $39.32 | |
| 85048 | 633 | 540 | $27.99 | |
| 0012A | 19 | 18 | $26.46 | |
| 83540 | 218 | 200 | $20.17 | |
| 83550 | 140 | 135 | $15.09 | |
| 0011A | 22 | 22 | $13.23 | |
| 90662 | 12 | 12 | $0.00 |